Mesoblast Limited (MESO)
NASDAQ: MESO · IEX Real-Time Price · USD
7.20
0.00 (0.00%)
At close: May 15, 2024, 4:00 PM
7.01
-0.19 (-2.64%)
After-hours: May 15, 2024, 7:52 PM EDT
Mesoblast Market Cap
Mesoblast has a market cap or net worth of $821.69 million as of May 16, 2024. Its market cap has increased by 52.39% in one year.
Market Cap
821.69M
Enterprise Value
866.14M
1-Year Change
52.39%
Ranking
Category
Stock Price
$7.20
Market Cap Chart
Since November 13, 2015, Mesoblast's market cap has increased from $593.20M to $821.69M, an increase of 38.52%. That is a compound annual growth rate of 3.90%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 15, 2024 | 730.70M | - |
May 14, 2024 | 730.70M | 3.16% |
May 13, 2024 | 708.30M | -5.17% |
May 10, 2024 | 746.90M | 2.65% |
May 9, 2024 | 727.60M | -5.53% |
May 8, 2024 | 770.20M | -4.60% |
May 7, 2024 | 807.30M | -0.69% |
May 6, 2024 | 812.90M | 6.81% |
May 3, 2024 | 761.10M | 2.88% |
May 2, 2024 | 739.80M | 1.11% |
May 1, 2024 | 731.70M | 9.24% |
Apr 30, 2024 | 669.80M | -7.04% |
Apr 29, 2024 | 720.50M | 13.79% |
Apr 26, 2024 | 633.20M | 1.46% |
Apr 25, 2024 | 624.10M | -1.12% |
Apr 24, 2024 | 631.20M | 3.66% |
Apr 23, 2024 | 608.90M | 8.50% |
Apr 22, 2024 | 561.20M | 6.15% |
Apr 19, 2024 | 528.70M | 1.95% |
Apr 18, 2024 | 518.60M | 2.01% |
Apr 17, 2024 | 508.40M | 6.83% |
Apr 16, 2024 | 475.90M | -9.30% |
Apr 15, 2024 | 524.70M | -3.71% |
Apr 12, 2024 | 544.90M | -6.29% |
Apr 11, 2024 | 581.50M | -1.21% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Atrion | 837.44M |
Silk Road Medical | 831.87M |
Zentalis Pharmaceuticals | 828.72M |
HealthStream | 828.65M |
Cytek Biosciences | 827.02M |
Dianthus Therapeutics | 820.00M |
Tango Therapeutics | 811.19M |
Arcturus Therapeutics Holdings | 800.95M |